Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13,213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.
Qi C, Gong J, Li J, Liu D, Qin Y, Ge S, Zhang M, Peng Z, Zhou J, Cao Y, Zhang X, Lu Z, Lu M, Yuan J, Wang Z, Wang Y, Peng X, Gao H, Liu Z, Wang H, Yuan D, Xiao J, Ma H, Wang W, Li Z, Shen L. Qi C, et al. Among authors: xiao j. Nat Med. 2022 Jun;28(6):1189-1198. doi: 10.1038/s41591-022-01800-8. Epub 2022 May 9. Nat Med. 2022. PMID: 35534566 Free PMC article. Clinical Trial.
A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials.
Yang M, Zhang W, Yu K, Wang P, Jiang H, Chen L, Meng H, Weng Y, Tao R, Huang X, Xing C, Wang H, Wan J, Wang S, Dai L, Hendrix AY, Xiao J, Wang W, Ma H, Hao S, Jin J, Li Z, Jiang S. Yang M, et al. Among authors: xiao j. Haematologica. 2022 Aug 1;107(8):1960-1965. doi: 10.3324/haematol.2022.280629. Haematologica. 2022. PMID: 35443566 Free PMC article. No abstract available.
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.
Qin C, Tian DS, Zhou LQ, Shang K, Huang L, Dong MH, You YF, Xiao J, Xiong Y, Wang W, Pang H, Guo JJ, Cai SB, Wang D, Li CR, Zhang M, Bu BT, Wang W. Qin C, et al. Among authors: xiao j. Signal Transduct Target Ther. 2023 Jan 4;8(1):5. doi: 10.1038/s41392-022-01278-3. Signal Transduct Target Ther. 2023. PMID: 36596762 Free PMC article. Clinical Trial.
Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study.
Mao Y, Liao Q, Zhu Y, Bi M, Zou J, Zheng N, Zhu L, Zhao C, Liu Q, Liu L, Chen J, Gu L, Liu Z, Pan X, Xue Y, Feng M, Ying T, Zhou P, Wu Z, Xiao J, Zhang R, Leng J, Sun Y, Zhang X, Xu J. Mao Y, et al. Among authors: xiao j. Cell Discov. 2024 May 14;10(1):49. doi: 10.1038/s41421-024-00658-z. Cell Discov. 2024. PMID: 38740803
13,213 results
You have reached the last available page of results. Please see the User Guide for more information.